Literature DB >> 19934752

The Diabetes Surgery Summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus.

Francesco Rubino1, Lee M Kaplan, Philip R Schauer, David E Cummings.   

Abstract

OBJECTIVES: To develop guidelines for the use of gastrointestinal surgery to treat type 2 diabetes and to craft an agenda for further research.
BACKGROUND: Increasing evidence demonstrates that bariatric surgery can dramatically ameliorate type 2 diabetes. Not surprisingly, gastrointestinal operations are now being used throughout the world to treat diabetes in association with obesity, and increasingly, for diabetes alone. However, the role for surgery in diabetes treatment is not clearly defined and there are neither clear guidelines for these practices nor sufficient plans for clinical trials to evaluate the risks and benefits of such "diabetes surgery."
METHODS: A multidisciplinary group of 50 voting delegates from around the world gathered in Rome, Italy for the first International Conference on Gastrointestinal Surgery to Treat Type 2 Diabetes--(the "Diabetes Surgery Summit"). During the meeting, available scientific evidence was examined and critiqued by the entire group to assess the strength of evidence and to draft consensus statements. Through an iterative process, draft statements were then serially discussed, debated, edited, reassessed, and finally presented for formal voting. After the Rome meeting, statements that achieved consensus were summarized and distributed to all voting delegates for further input and final approval. These statements were then formally critiqued by representatives of several sientific societies at the 1st World Congress on Interventional Therapies for T2DM (New York, Sept 2008). Input from this discussion was used to generate the current position statement.
RESULTS: A Diabetes Surgery Summit (DSS) Position Statement consists of recommendations for clinical and research issues, as well as general concepts and definitions in diabetes surgery. The DSS recognizes the legitimacy of surgical approaches to treat diabetes in carefully selected patients. For example, gastric bypass was deemed a reasonable treatment option for patients with poorly controlled diabetes and a body mass index > or =30 kg/m. Clinical trials to investigate the exact role of surgery in patients with less severe obesity and diabetes are considered a priority. Furthermore, investigations on the mechanisms of surgical control of diabetes are strongly encouraged, as they may help advance the understanding of diabetes pathophysiology.
CONCLUSIONS: The DSS consensus document embodies the foundations of "diabetes surgery," and represents a timely attempt by leading scholars to improve access to surgical options supported by sound evidence, while also preventing harm from inappropriate use of unproven procedures.

Entities:  

Mesh:

Year:  2010        PMID: 19934752     DOI: 10.1097/SLA.0b013e3181be34e7

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  107 in total

1.  Metabolic laparoscopic gastric bypass for obese patients with type 2 diabetes.

Authors:  Mário Nora; Marta Guimarães; Rui Almeida; Paulo Martins; Gil Gonçalves; Maria José Freire; Tiago Ferreira; Cláudia Freitas; Mariana P Monteiro
Journal:  Obes Surg       Date:  2011-11       Impact factor: 4.129

Review 2.  Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.

Authors:  C Dirksen; N B Jørgensen; K N Bojsen-Møller; S H Jacobsen; D L Hansen; D Worm; J J Holst; S Madsbad
Journal:  Diabetologia       Date:  2012-04-27       Impact factor: 10.122

3.  At the heart of the benefits of bariatric surgery.

Authors:  David E Cummings; Stephen R Bloom; Francesco Rubino
Journal:  Nat Med       Date:  2012-03-06       Impact factor: 53.440

4.  Bariatric surgery as treatment for type 2 diabetes.

Authors:  George L Blackburn; Samuel B Wollner; Daniel B Jones
Journal:  Curr Diab Rep       Date:  2010-08       Impact factor: 4.810

5.  The big fat bariatric bandwagon.

Authors:  J H Pinkney; A B Johnson; E A M Gale
Journal:  Diabetologia       Date:  2010-09       Impact factor: 10.122

Review 6.  How Durable Are the Effects After Metabolic Surgery?

Authors:  Tarissa Beatrice Zanata Petry; Pedro Paulo Caravatto; Fernando Quirino Pechy; Jose Luis Lopes Correia; Catia Cristina Lorenzi Guerbali; Regina Marcelina da Silva; João Eduardo Salles; Ricardo Cohen
Journal:  Curr Atheroscler Rep       Date:  2015-09       Impact factor: 5.113

7.  Strategies for preventing type 2 diabetes: an update for clinicians.

Authors:  Kaivan Khavandi; Halima Amer; Bashar Ibrahim; Jack Brownrigg
Journal:  Ther Adv Chronic Dis       Date:  2013-09       Impact factor: 5.091

8.  Diabetes: treatment of type 2 diabetes mellitus with bariatric surgery.

Authors:  Peter Clifton
Journal:  Nat Rev Endocrinol       Date:  2010-04       Impact factor: 43.330

9.  Diabetes remission and insulin secretion after gastric bypass in patients with body mass index <35 kg/m2.

Authors:  Wei-Jei Lee; Keong Chong; Chih-Yen Chen; Shu-Chun Chen; Yi-Chih Lee; Kong-Han Ser; Lee-Ming Chuang
Journal:  Obes Surg       Date:  2011-07       Impact factor: 4.129

10.  The Impact of Preoperative BMI (Obesity Class I, II, and III) on the 12-Month Evolution of Patients Undergoing Laparoscopic Gastric Bypass.

Authors:  Eva M Ramírez; Omar Espinosa; Ricardo Berrones; Elisa M Sepúlveda; Lizbeth Guilbert; Miguel Solís; Carlos Zerrweck
Journal:  Obes Surg       Date:  2018-10       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.